![Nigel Theobald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nigel Theobald
Geen lopende functies
Vermogen: 146 549 $ op 30-06-2026
Profiel
Nigel James Theobald is the founder of Abaco Capital Plc, founded in 2009.
Mr. Theobald was the founder of N4 Pharma Plc, founded in 2014, and held the title of Chief Executive Officer & Executive Director from 2017 to 2026.
Mr. Theobald was the founder of N4 Pharma UK Ltd., founded in 2014, and held the title of Chief Executive Officer.
Mr. Theobald was a Non-Executive Director at Medherant Ltd. Mr. Theobald was Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald completed undergraduate education at The University of Southampton.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-04-2025 | 16.981.319 ( 2,04% ) | 146 549 $ | 30-06-2026 |
Eerdere bekende functies van Nigel Theobald
| Bedrijven | Functie | Einde |
|---|---|---|
| THALIA THERAPEUTICS PLC | Oprichter | 24-02-2026 |
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Corporate Officer/Principal | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Directeur/Bestuurslid | - |
N4 Pharma Ltd.
 N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Algemeen Directeur | - |
| ABACO CAPITAL PLC | Oprichter | - |
Opleiding van Nigel Theobald
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abaco Capital Plc
 Abaco Capital Plc Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
